Abstract:
A closed-loop therapy delivery system for modulating uterine function in a mammal can include: at least one electrode configured to deliver an electric current to a spinal cord target associated with uterine function; a power source in electrical communication with the at least one electrode; at least one sensor in electrical communication with the at least one electrode; and a controller in electrical communication with each of the at least one electrode and the at least one sensor. The controller can be configured to automatically coordinate operation of the power source. The controller can be configured to direct delivery of the electric current to the at least one electrode to deliver a therapy signal to the spinal cord target in an amount and for a time sufficient to effect a change in sympathetic and/or parasympathetic activity in the mammal and thereby modulate uterine function.